Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CM8 | ISIN: KYG3314S1066 | Ticker-Symbol: 5UD
Frankfurt
30.01.26 | 08:21
0,288 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
FANGZHOU INC Chart 1 Jahr
5-Tage-Chart
FANGZHOU INC 5-Tage-Chart

Aktuelle News zur FANGZHOU Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoFANGZHOU JIANKE (06086): NEXT DAY DISCLOSURE RETURN-
MoFANGZHOU JIANKE (06086): COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE1
27.01.Fangzhou Inc.: Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit293SHANGHAI, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, issued a positive profit forecast...
► Artikel lesen
FANGZHOU Aktie jetzt für 0€ handeln
27.01.Fangzhou Inc.: Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform1
27.01.FANGZHOU JIANKE Tumbles 13%+ on ~12% Discounted Top-up Placement2
27.01.FANGZHOU JIANKE Announces ~12% Discounted Top-Up Placing to Finance AI-Driven Chronic Disease Mgmt Platform Expansion2
27.01.FANGZHOU JIANKE (06086): PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE2
25.01.Fangzhou Projects 30% Revenue Growth In 20251
13.01.FANGZHOU JIANKE (06086): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES-
08.12.25FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
07.12.25FANGZHOU JIANKE (06086): CHANGE OF CHAIRMAN, CHIEF EXECUTIVE OFFICER AND AUTHORISED REPRESENTATIVE; RE-DESIGNATION OF DIRECTOR; CHANGE IN THE COMPOSITION ...-
27.11.25Fangzhou Inc.: Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management10
08.11.25Fangzhou Inc.: Fangzhou Awarded "Golden Bull Award" for Leadership in AI-Powered Chronic Disease Management1
07.11.25Fangzhou Inc.: Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE563SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the "Boundless...
► Artikel lesen
02.11.25Fangzhou Inc.: Fangzhou's "XingJie" LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations1
29.10.25Fangzhou Inc.: Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management240SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group)...
► Artikel lesen
26.09.25Fangzhou Inc.: Fangzhou's 'XingShi' LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care1
25.09.25FANGZHOU JIANKE (06086): 2025 INTERIM REPORT-
18.09.25Fangzhou Inc.: Fangzhou Named 'Outstanding Growth Story in Hong Kong Stocks' at China Capital Market Development Forum 20251
18.09.25Fangzhou Inc.: Fangzhou Wins Gilead 'Award of Excellence' for AI-Driven Chronic Disease Management13
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1